Retroviral DNA integration, Chem Rev, vol.116, pp.12730-57, 2016. ,
The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication, PLoS Pathog, vol.4, p.1000046, 2008. ,
A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin, Proc Natl Acad Sci, vol.113, pp.1054-63, 2016. ,
HIV-1 integrase forms stable tetramers and associates with LEDGF/ p75 protein in human cells, J Biol Chem, vol.278, pp.372-81, 2003. ,
Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication, J Biol Chem, vol.280, pp.25517-25540, 2005. ,
Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication, Nat Chem Biol, vol.6, pp.442-450, 2010. ,
cooperative mechanism of action of allosteric HIV-1 integrase inhibitors, J Biol Chem, vol.287, pp.16801-16812, 2012. ,
New class of HIV-1 integrase (IN) inhibitors with a dual mode of action, J Biol Chem, vol.287, pp.21189-203, 2012. ,
Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells, PLoS ONE, vol.8, p.74163, 2013. ,
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor, Antimicrob Agents Chemother, vol.58, pp.3233-3277, 2014. ,
A new class of multimerization selective inhibitors of HIV-1 integrase, PLoS Pathog, vol.10, p.1004171, 2014. ,
Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage, Retrovirology, vol.10, p.144, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00914180
Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization, Antimicrob Agents Chemother, vol.56, pp.4365-74, 2012. ,
LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions, Retrovirology, vol.10, p.57, 2013. ,
Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation, Proc Natl Acad Sci, vol.110, pp.8690-8695, 2013. ,
Distribution and redistribution of HIV-1 nucleocapsid protein in immature, mature, and integrase-inhibited virions: a role for integrase in maturation, J Virol, vol.89, pp.9765-80, 2015. ,
HIV-1 integrase binds the viral RNA genome and is essential during virion morphogenesis, Cell, vol.166, p.12, 2016. ,
LEDGIN-mediated inhibition of Integrase-LEDGF/p75 interaction reduces reactivation of residual latent HIV, EBioMedicine, vol.8, pp.248-64, 2016. ,
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review, Vaccine, vol.29, pp.6191-218, 2011. ,
Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection, Vaccine, vol.29, pp.6454-63, 2011. ,
A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication, Sci Transl Med, vol.5, pp.166-168, 2013. ,
Inhibitors of viral replication, their process of preparation and their therapeutical uses ,
The allosteric HIV-1 Integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome, PLoS ONE, vol.9, p.103552, 2014. ,
Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses, AIDS Res Hum Retroviruses, vol.23, pp.532-574, 2007. ,
Significance of premature stop codons in env of simian immunodeficiency virus, J Virol, vol.63, pp.4709-4723, 1989. ,
Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques, Mucosal Immunol, vol.7, pp.46-56, 2014. ,
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1, Science, vol.329, pp.856-61, 2010. ,
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target, Science, vol.326, pp.285-294, 2009. ,
Structural definition of a conserved neutralization epitope on HIV-1 gp120, Nature, vol.445, pp.732-739, 2007. ,
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1, J Virol, vol.70, pp.1100-1108, 1996. ,
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1, J Virol, vol.67, pp.6642-6649, 1993. ,
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1, AIDS Res Hum Retroviruses, vol.17, pp.1757-65, 2001. ,
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41, J Virol, vol.75, pp.10892-905, 2001. ,
Efficient generation of human IgA monoclonal antibodies, J Immunol Methods, vol.422, pp.102-112, 2015. ,
Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies, Immunity, vol.37, pp.412-437, 2012. ,
Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41, Virology, vol.333, pp.102-115, 2005. ,
A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1, J Immunol Methods, vol.253, pp.253-62, 2001. ,
Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals, PLoS ONE, vol.6, p.19644, 2011. ,
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI, Virology, vol.185, pp.661-72, 1991. ,
Morphology and ultrastructure of retrovirus particles, AIMS Biophys, vol.2, pp.343-69, 2015. ,
Inactivated influenza virus, when presented on dendritic cells, elicits human CD8 + cytolytic T cell responses, J Exp Med, vol.182, pp.1663-71, 1995. ,
Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus, AIDS, vol.16, pp.1319-1348, 2002. ,
MHC-I-restricted presentation of HIV-1 virion antigens without viral replication, Nat Med, vol.7, pp.344-353, 2001. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01372734
Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals, PLoS ONE, vol.8, p.58927, 2013. ,
Will LEDGIN molecules be able to play a role in a cure for HIV infection?, EBioMedicine, vol.8, pp.14-19, 2016. ,